Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2712629rdf:typepubmed:Citationlld:pubmed
pubmed-article:2712629lifeskim:mentionsumls-concept:C1522564lld:lifeskim
pubmed-article:2712629lifeskim:mentionsumls-concept:C0021308lld:lifeskim
pubmed-article:2712629lifeskim:mentionsumls-concept:C0003968lld:lifeskim
pubmed-article:2712629lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:2712629lifeskim:mentionsumls-concept:C0442967lld:lifeskim
pubmed-article:2712629lifeskim:mentionsumls-concept:C0147003lld:lifeskim
pubmed-article:2712629pubmed:issue4lld:pubmed
pubmed-article:2712629pubmed:dateCreated1989-6-2lld:pubmed
pubmed-article:2712629pubmed:abstractTextBoth Trolox (a water-soluble analogue of alpha-tocopherol) and ascorbic acid were more effective than superoxide dismutase or catalase in protecting myocyte cell cultures from free radical attack (induced by hypoxanthine and xanthine oxidase). In a canine model of two hours of left anterior descending coronary artery occlusion followed by four hours of reperfusion, Trolox and ascorbic acid reduced the area of infarction within the area at risk. The Trolox group received 500 mL of deoxygenated saline solution containing 2.0 g of Trolox, 3.0 g of ascorbic acid, and 18 mg of EDTA (ethylenediaminetetraacetic acid) infused into the ascending aorta 30 seconds before and four minutes after reperfusion. Saline controls received 500 mL of deoxygenated saline solution containing 18 mg of EDTA. The angioplasty group had unmodified reperfusion by simple release of the occlusion. The area at risk and the area infarcted were estimated with Evans blue and triphenyl tetrazolium hydrochloride stains, respectively. The ratio of the area infarcted to the area at risk was significantly lower with Trolox (angioplasty, 30.4% +/- 5.1%; saline, 20.8% +/- 2.9%; and Trolox, 8.7% +/- 4.0%; p less than 0.01). In summary, the antioxidants Trolox and ascorbic acid effectively reduced myocardial necrosis after ischemia.lld:pubmed
pubmed-article:2712629pubmed:languageenglld:pubmed
pubmed-article:2712629pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2712629pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2712629pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2712629pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2712629pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2712629pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2712629pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2712629pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2712629pubmed:statusMEDLINElld:pubmed
pubmed-article:2712629pubmed:monthAprlld:pubmed
pubmed-article:2712629pubmed:issn0003-4975lld:pubmed
pubmed-article:2712629pubmed:authorpubmed-author:JackowskiGGlld:pubmed
pubmed-article:2712629pubmed:authorpubmed-author:WeiselR DRDlld:pubmed
pubmed-article:2712629pubmed:authorpubmed-author:BurtonG WGWlld:pubmed
pubmed-article:2712629pubmed:authorpubmed-author:WuT WTWlld:pubmed
pubmed-article:2712629pubmed:authorpubmed-author:MickleD ADAlld:pubmed
pubmed-article:2712629pubmed:authorpubmed-author:MadonikM MMMlld:pubmed
pubmed-article:2712629pubmed:authorpubmed-author:BirnbaumP LPLlld:pubmed
pubmed-article:2712629pubmed:authorpubmed-author:LiR KRKlld:pubmed
pubmed-article:2712629pubmed:authorpubmed-author:IngoldK UKUlld:pubmed
pubmed-article:2712629pubmed:issnTypePrintlld:pubmed
pubmed-article:2712629pubmed:volume47lld:pubmed
pubmed-article:2712629pubmed:ownerNLMlld:pubmed
pubmed-article:2712629pubmed:authorsCompleteYlld:pubmed
pubmed-article:2712629pubmed:pagination553-7lld:pubmed
pubmed-article:2712629pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2712629pubmed:meshHeadingpubmed-meshheading:2712629-...lld:pubmed
pubmed-article:2712629pubmed:meshHeadingpubmed-meshheading:2712629-...lld:pubmed
pubmed-article:2712629pubmed:meshHeadingpubmed-meshheading:2712629-...lld:pubmed
pubmed-article:2712629pubmed:meshHeadingpubmed-meshheading:2712629-...lld:pubmed
pubmed-article:2712629pubmed:meshHeadingpubmed-meshheading:2712629-...lld:pubmed
pubmed-article:2712629pubmed:meshHeadingpubmed-meshheading:2712629-...lld:pubmed
pubmed-article:2712629pubmed:meshHeadingpubmed-meshheading:2712629-...lld:pubmed
pubmed-article:2712629pubmed:meshHeadingpubmed-meshheading:2712629-...lld:pubmed
pubmed-article:2712629pubmed:meshHeadingpubmed-meshheading:2712629-...lld:pubmed
pubmed-article:2712629pubmed:meshHeadingpubmed-meshheading:2712629-...lld:pubmed
pubmed-article:2712629pubmed:meshHeadingpubmed-meshheading:2712629-...lld:pubmed
pubmed-article:2712629pubmed:meshHeadingpubmed-meshheading:2712629-...lld:pubmed
pubmed-article:2712629pubmed:meshHeadingpubmed-meshheading:2712629-...lld:pubmed
pubmed-article:2712629pubmed:meshHeadingpubmed-meshheading:2712629-...lld:pubmed
pubmed-article:2712629pubmed:meshHeadingpubmed-meshheading:2712629-...lld:pubmed
pubmed-article:2712629pubmed:year1989lld:pubmed
pubmed-article:2712629pubmed:articleTitleMyocardial salvage with trolox and ascorbic acid for an acute evolving infarction.lld:pubmed
pubmed-article:2712629pubmed:affiliationDepartment of Clinical Biochemistry, Toronto General Hospital, University of Toronto, Ontario, Canada.lld:pubmed
pubmed-article:2712629pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2712629pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2712629lld:pubmed